207
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Differential modes of photosensitisation in cancer cells by berberine and coralyne

, , , , &
Pages 723-738 | Received 23 Apr 2017, Accepted 14 Aug 2017, Published online: 05 Sep 2017

References

  • Postiglione I, Chiaviello A, Palumbo G. Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategies. Cancers 2011;3:2597–2629.
  • Peterson CM, Lu JM, Sun Y, Peterson CA, Shiah JG, Straight RC, Kopecek J. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Cancer Res 1996;56:3980–3985.
  • Canti G, Calastretti A, Bevilacqua A, Reddi E, Palumbo G, Nicolin A. Combination of photodynamic therapy + immunotherapy + chemo-therapy in murine leukiemia. Neoplasma 2010;57:184–188.
  • Müller B, Sola JA, Carcamo M, Ciudad AM, Trujillo C, Cerda B. Adjuvant chemoradiation for resected gallbladder cancer: treatment strategies for one of the leading causes of cancer death in Chilean women. Indian J Cancer 2013;50:184–188.
  • Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. AntiCancer Drugs 2009;20:757–769.
  • Lu JJ, Bao JL, Chen XP, Huang M, Wang YT. Alkaloids isolated from natural herbs as the anticancer agents. Evid Based Complement Alternat Med 2012;2012:485042.
  • Patro BS, Maity B, Chattopadhyay S. Topoisomerase inhibitor-coralyne photosensitizes DNA through the generation of photoproduct, leading to elicitation of Chk2 dependent S-phase checkpoint and p53-independent apoptosis in cancer cells. Antioxid Redox Signal 2010;12:945–960.
  • Ihmels H, Salbach A. Efficient photoinduced DNA damage by coralyne. Photochem Photobiol 2006;82:1572–1576.
  • Brezová V, Dvoranová D, Kost’álová D. Oxygen activation by photoexcited protoberberinium alkaloids from Mahonia aquifolium. Phytother Res 2004;18:640–646.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
  • de Arriba SG, Krügel U, Regenthal R, Vissiennon Z, Verdaguer E, Lewerenz A, et al. Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity. Free Radic Biol Med 2006;40:779–790.
  • Marra M, Lombardi A, Agostinelli E, Giuberti G, Zappavigna S, Tempera G, et al. Bovine serum amineoxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. Biochim Biophys Acta 2008;1783:2269–2278.
  • Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y, Liu LF. Topoisomerase IIβ–mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res 2007;67:8839–8846.
  • Bossy-Wetzel E, Green DR. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 1999;274:17484–17490.
  • Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993;197:40–45.
  • Alolga RN, Fan Y, Chen Z, Liu L-W, Zhao YJ, Li J, et al. Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. Sci Rep 2016;6:Article number: 27671.
  • Manda G, Nechifor MT, Neagu TM. Reactive oxygen species, cancer and anti-cancer therapies. Curr Chem Biol 2009;3:342–366.
  • Stratton SP, Liebler DC. Determination of singlet oxygen-specific versus radical-mediated lipid peroxidation in photosensitized oxidation of lipid bilayers: effect of β-carotene and α-tocopherol. Biochemistry 1997;36:12911–12920.
  • Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 2008;8:193–204.
  • Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858–5868.
  • Arnaudeau C, Lundin C, Helleday T. DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J Mol Biol 2001;307:1235–1245.
  • Madhusudhanan N, Ruckmani A, Gowtham KS, Ramakrishnan V, Balasubramanian MP, Konda VGR. In vitro cytotoxic activity of berberine on human lung carcinoma cell line A549. J Pharm Res 2011;4:4504–4506.
  • Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004;116:205–219.
  • Wong RSY. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 2011;30:87.
  • Hickman JA. Apoptosis and chemotherapy resistance. Eur J Cancer 1996;32A:921–926.
  • Laustriat G. Molecular mechanisms of photosensitization. Biochimie 1986;68:771–778.
  • Wardman P. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic Biol Med 2007;43:995–1022.
  • Kalyanaraman B, Hardy M, Zielonka J. A critical review of methodologies to detect reactive oxygen and nitrogen species stimulated by NADPH oxidase enzymes: implications in pesticide toxicity. Curr Pharmacol Rep 2016;2:193–201.
  • McKinnon PJ, Caldecott KW. DNA strand break repair and human genetic disease. Annu Rev Genomics Hum Genet 2007;8:37–55.
  • Sedelnikova OA, Bonner WM. γH2AX in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrence. Cell Cycle 2006;5:2909–2913.
  • Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. γH2AX and cancer. Nat Rev Cancer 2008;8:957–967.
  • DiTullio Jr. RA, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J, Halazonetis TD. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol 2002;4:998–1002.
  • Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 2000;151:1381–1390.
  • Fradet-Turcotte A, Canny MD, Escribano-Díaz C, Orthwein A, Leung CC, Huang H, et al. 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature 2013;499:50–54.
  • Kuo CL, Chou CC, Yung BY. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett 1995;93:193–200.
  • Tsang CM, Lau EP, Di K, Cheung PY, Hau PM, Ching YP,et al. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med 2009;24:131–138.
  • Patil JB, Kim J, Jayaprakasha GK. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol 2010;645:70–78.
  • Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, et al. The alkaloid berberine inhibits the growth of anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 2010;17:436–440.
  • Qi HW, Xin LY, Xu X, Ji XX, Fan LH. Epithelial-to-mesenchymal transition markers to predict response of berberine in suppressing lung cancer invasion and metastasis. J Transl Med 2014;12:22.
  • Katiyar SK, Meeran SM, Katiyar N, Akhtar S. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog 2009;48:24–37.
  • Zheng F, Tang Q, Wu J, Zhao SY, Liang ZY, Li L, et al. P38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine. J Exp Clin Cancer Res 2014;33:36.
  • Tong N, Zhang J, Chen Y, Li Z, Luo Y, Zuo H, Zhao X. Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncol Lett 2012;3:1263–1267.
  • Balakrishna A, Kumar MH. Evaluation of synergetic anticancer activity of berberine and curcumin on different models of A549, Hep-G2, MCF-7, Jurkat, and K562 cell lines. Biomed Res Int 2015;2015:354614.
  • Tan W, Li Y, Chen M, Wang Y. Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. Int J Nanomed 2011;6:1773–1777.
  • Jantová S, Letašiová S, Brezová V, Cipák L, Lábaj J. Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells. J Photochem Photobiol B 2006;85:163–176.
  • Tait SWG, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010;11:621–632.
  • Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342–348.
  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479–489.
  • Sirbu BM, Couch FB, Feigerle JT, Bhaskara S, Hiebert SW, Cortez D. Analysis of protein dynamics at active, stalled, and collapsed replication forks. Genes Dev 2011;25:1320–1327.
  • Garcez AS, Fregnani ER, Rodriguez HM, Nunez SC, Sabino CP, Suzuki H, Ribeiro MS. The use of optical fiber in endodontic photodynamic therapy. Is it really relevant? Lasers Med Sci 2013;28:79–85.
  • Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, et al. Photodynamic therapy (PDT) for malignant brain tumors – where do we stand? Photodiagnosis Photodyn Ther 2015;12:530–544.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.